SIPAI HEALTH TECHNOLOGY CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.2 USD | +4.03% |
|
+2.65% | -10.14% |
| Mar. 19 | Sipai Health Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 05 | Sipai Health Technology Expects to Narrow Loss in Full Year 2023 | MT |
Valuation
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Capitalization 1 | 12,588 | 4,776 | 4,375 | - | - |
| Enterprise Value (EV) 1 | 11,201 | 4,776 | 4,090 | 4,175 | 3,983 |
| P/E ratio | - | - | - | - | - |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | 3.06 x | 1.01 x | 0.84 x | 0.74 x | 0.66 x |
| EV / Revenue | 2.72 x | 1.01 x | 0.79 x | 0.71 x | 0.6 x |
| EV / EBITDA | -19.2 x | -39.2 x | -12 x | -15.6 x | -15.6 x |
| EV / FCF | - | - | - | - | - |
| FCF Yield | - | - | - | - | - |
| Price to Book | 1.01 x | - | 2.75 x | 2.65 x | 2.47 x |
| Nbr of stocks (in thousands) | 763,025 | 761,500 | 762,156 | - | - |
| Reference price 2 | 16.50 | 6.271 | 5.740 | 5.740 | 5.740 |
| Announcement Date | 3/15/23 | 3/19/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net sales 1 | 4,119 | 4,712 | 5,196 | 5,896 | 6,670 |
| EBITDA 1 | -583.7 | -121.8 | -341 | -268 | -255 |
| EBIT 1 | -633.2 | -174.7 | -218.7 | -126 | -84.92 |
| Operating Margin | -15.37% | -3.71% | -4.21% | -2.14% | -1.27% |
| Earnings before Tax (EBT) | - | - | - | - | - |
| Net income | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| EPS | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - |
| FCF margin | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - |
| Announcement Date | 3/15/23 | 3/19/24 | - | - | - |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - |
| Net Cash position 1 | 1,388 | - | 284 | 200 | 392 |
| Leverage (Debt/EBITDA) | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - |
| ROE (net income / shareholders' equity) | - | - | -3.24% | 3.22% | 6.5% |
| ROA (Net income/ Total Assets) | - | - | - | - | - |
| Assets | - | - | - | - | - |
| Book Value Per Share 2 | 16.30 | - | 2.090 | 2.170 | 2.320 |
| Cash Flow per Share | - | - | - | - | - |
| Capex | - | - | - | - | - |
| Capex / Sales | - | - | - | - | - |
| Announcement Date | 3/15/23 | 3/19/24 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
5.74
CNY
Average target price
7.893
CNY
Spread / Average Target
+37.51%
Chiffre d''affaires - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -10.14% | 605M | |
| -31.48% | 15.43B | |
| -22.25% | 12.31B | |
| -25.47% | 6.59B | |
| +12.51% | 6.3B | |
| -9.71% | 5.88B | |
| -0.15% | 4.74B | |
| +60.03% | 4.7B | |
| -4.98% | 4.03B | |
| -8.76% | 3.58B |
- Stock Market
- Equities
- 314 Stock
- Financials Sipai Health Technology Co., Ltd.
